Changes in Parvovirus B19 positivity rates in plasma units for fractionation: An unexpected effect of non-pharmaceutical interventions against COVID-19?
Vox Sang
.
2022 Apr;117(4):626-627.
doi: 10.1111/vox.13229.
Epub 2021 Dec 8.
Authors
Silvia Sauleda
1
2
3
,
Maria Piron
1
2
3
,
Marta Bes
1
2
3
,
Nuria Martinez-Llonch
1
,
Lluis Puig
1
2
Affiliations
1
Transfusion Safety Laboratory, Banc de Sang i Teixits (Blood and Tissue Bank, BST), Barcelona, Spain.
2
CIBER Liver and Digestive Diseases (CIBERHED), Institute of Health Carlos III, Madrid, Spain.
3
Vall d'Hebron Institute of Research (VHIR), Vall d'Hebron University Hospital, Barcelona, Spain.
PMID:
34877666
DOI:
10.1111/vox.13229
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Viral
COVID-19*
DNA, Viral
Humans
Parvoviridae Infections*
Parvovirus B19, Human* / genetics
Substances
Antibodies, Viral
DNA, Viral